Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition and method for treating bladder cancer

A technology for bladder cancer and bladder cancer cells, applied in drug combinations, carbohydrate active ingredients, medical raw materials derived from bacteria, etc., can solve problems such as side effects, toxicity, drug resistance or immune sensitization development

Inactive Publication Date: 2004-06-16
贝尔尼奇泌尿知识产权公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many of these agents are ineffective or toxic, have significant side effects, lead to the development of resistance or immune sensitization, and debilitate recipients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition and method for treating bladder cancer
  • Composition and method for treating bladder cancer
  • Composition and method for treating bladder cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Preparation of MCC from Mycobacterium phlei and Purification of M-DNA from MCC and Mycobacterium phlei

[0059] MCC was prepared from Mycobacterium phlei (110 strains), M-DNA was purified from MCC (MCC-DNA), M-DNA was purified from Mycobacterium phlei (Mycobacterium phlei- DNA). All reagents are selected to enhance DNA preservation. Unless otherwise stated, MCC, MCC-DNA, and M. phlei-DNA were resuspended in DNase-free water or a pharmaceutically acceptable DNase-free buffer by Sonication for emulsification. MCC, MCC-DNA and M. phlei-DNA were free of endotoxin as determined using the Limulus Amoeba-like Cell Lysate QCL-1000 Kit (BioWhittaker, Walkersville, MD).

Embodiment 2

[0061] Preparation of bacterial-DNA-bacterial cell wall complexes and bacterial DNA from other bacterial species

[0062] As described in Example 1, from Mycobacterium smegmatis, Mycobacterium fortuitum, Nocardia rubra (Nocardia rubra), Nocardia asteroides (Nicardia asteroides), Corynebacterium parvum, Kansas Mycobacterium, M. tuberculosis and M. bovis produce bacterial DNA-bacterial cell wall complex (BCC) and bacteria-DNA (B-DNA).

Embodiment 3

[0064] DNase treatment

[0065] At 25°C, in 20mM Tris HCl, pH 8.4, 2mM MgCl 2 and 50 mM KCl, MCC-DNA containing 1 μg of M-DNA and MCC and Regressin® (US Patent 4744984) were digested with 1 International Unit (IU) of RNase-free DNase I (Life Technologies) for 1 Hour. DNase I was inactivated by adding EDTA to a final concentration of 2.5 mM and heating at 65°C for 10 minutes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a composition and method for treating cancer in the urinary bladder. More particularly, the present invention relates to a composition comprising a Mycobacterium phlei (M. phlei) deoxyribonucleic acid (M-DNA)-M. phlei cell wall complex (MCC), wherein the M-DNA is preserved and complexed on the M. phlei cell wall, and a pharmaceutically acceptable carrier. The MCC composition inhibits proliferation of and induces apoptosis in the cancer cells in the urinary bladder of the animal.

Description

field of invention [0001] This application incorporates by reference US Provisional Application 60 / 075111, filed February 18, 1998, which is claimed in its entirety. [0002] The present invention comprises a mycobacterial deoxyribonucleic acid (B-DNA)-mycobacterial cell wall complex (BCC), wherein the B-DNA is preserved and complexed on the bacterial cell wall, enabling the BCC to be effective in the treatment of bladder cancer . More specifically, the present invention comprises a Mycobacterium phlei (M. phpei)-DNA (M-DNA)-Mycobacterium phlei cell wall complex (MCC), wherein the M-DNA is preserved and Compounded on the cell wall of Mycobacterium phlei, MCC can effectively inhibit the proliferation of bladder cancer cells and induce cell apoptosis. Background of the invention [0003] Cancer is an abnormal net accumulation of atypical cells that can result from hyperproliferation, inadequate apoptosis, or a combination of both. Apoptosis is initiated by ligand binding to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7088A61K31/70A61K35/74A61K47/48A61P13/10A61P35/00
CPCA61K31/713A61K47/48776A61K31/711A61K47/6901A61P13/10A61P35/00
Inventor 奈杰尔·C·菲利普斯马里翁·C·菲利翁
Owner 贝尔尼奇泌尿知识产权公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com